A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline

被引：0
|
作者：
Nicholas Van Hise
Russell M. Petrak
Nathan C. Skorodin
Robert M. Fliegelman
Michael Anderson
Vishal Didwania
Alice Han
Kairav Shah
Vishnu Chundi
David Hines
Ingrid Roig
Apoorv Kalra
机构：
[1] Metro Infectious Disease Consultants,
[2] Metro Infectious Disease Consultants,undefined
[3] Metro Infectious Disease Consultants,undefined
[4] Metro Infectious Disease Consultants,undefined
来源：
Infectious Diseases and Therapy | 2020年 / 9卷
关键词：
Adverse events; Clinical efficacy; Eravacycline; Real-world;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1017 / 1028
页数：11
相关论文
共 50 条
  • [1] A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline
    Van Hise, Nicholas
    Petrak, Russell M.
    Skorodin, Nathan C.
    Fliegelman, Robert M.
    Anderson, Michael
    Didwania, Vishal
    Han, Alice
    Shah, Kairav
    Chundi, Vishnu
    Hines, David
    Roig, Ingrid
    Kalra, Apoorv
    [J]. INFECTIOUS DISEASES AND THERAPY, 2020, 9 (04) : 1017 - 1028
  • [2] Eravacycline: a comprehensive review of in vitro activity, clinical efficacy, and real-world applications
    Huang, Po-Yu
    Hsu, Chi-Kuei
    Tang, Hung-Jen
    Lai, Chih-Cheng
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (06) : 387 - 398
  • [3] Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release Calcifediol
    Fadda, George
    Germain, Michael J.
    Broumand, Varshasb
    Nguyen, Andy
    McGarvey, November
    Gitlin, Matthew
    Bishop, Charles W.
    Ashfaq, Akhtar
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2021, 52 (10-11) : 798 - 807
  • [4] Leveraging Real-World Data in Safety Signal Assessment
    Patadia, Vaishali
    Manlik, Katrin
    Gipson, Geoffrey
    Willis, Jenna C.
    Namuyinga, Ruth
    Mcdermott, Rachel
    Shaw, Anita
    Miller, Mary K.
    Asubonteng, Julius
    Golchin, Negar
    von Klot, Stephanie
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024,
  • [5] Real-world evidence in safety assessment of new treatments
    Smedby, Karin E.
    Eloranta, Sandra
    [J]. LANCET HAEMATOLOGY, 2018, 5 (11): : E510 - E511
  • [6] REAL-WORLD ASSESSMENT: CLINICAL EFFECTIVENESS AND SAFETY OF EXTENDED-RELEASE CALCIFEDIOL (ERC)
    Fadda, George
    Germain, Michael
    Broumand, Varshasb
    Nguyen, Andy
    McGarvey, November
    Gitlin, Matthew
    Ashfaq, Akhtar
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 567 - 567
  • [7] RETROSPECTIVE REAL-WORLD ASSESSMENT OF RESPONSE OUTCOMES IN ONCOLOGY
    Espirito, J. L.
    Aguilar, K.
    Boyd, M.
    Frytak, J.
    Robert, N. J.
    [J]. VALUE IN HEALTH, 2019, 22 : S389 - S389
  • [8] Assessment of Botulinum Toxin Aesthetic Outcomes Clinical Study vs Real-World Practice
    Glogau, Richard
    Biesman, Brian
    Kane, Michael
    [J]. JAMA DERMATOLOGY, 2015, 151 (11) : 1177 - 1178
  • [9] Rapid use of real-world data in safety signal assessment
    McDermott, Rachel
    Patadia, Vaishali
    von Klot, Stephanie
    Asubonteng, Julius
    Miller, Mary K.
    Golchin, Negar
    Manlik, Katrin
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 496 - 497
  • [10] Postmarketing Safety Concerns of Teprotumumab: A Real-World Pharmacovigilance Assessment
    Huang, Jing
    Su, Anping
    Yang, Jing
    Zhuang, Wei
    Li, Zhihui
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
12345